165 related articles for article (PubMed ID: 36718563)
1. Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19.
Lee J; Chang E; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Bae S
J Korean Med Sci; 2023 Jan; 38(4):e37. PubMed ID: 36718563
[TBL] [Abstract][Full Text] [Related]
2. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
Liu HH; Yaron D; Piraino AS; Kapelusznik L
Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
[TBL] [Abstract][Full Text] [Related]
3. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
4. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
7. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
[TBL] [Abstract][Full Text] [Related]
8. Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission.
Antuori A; Giménez M; Linares G; Cardona PJ
Sci Rep; 2023 Nov; 13(1):19302. PubMed ID: 37935785
[TBL] [Abstract][Full Text] [Related]
9. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis.
Calderon M; Gysin G; Gujjar A; McMaster A; King L; Comandé D; Hunter E; Payne B
BMC Infect Dis; 2023 Jan; 23(1):14. PubMed ID: 36624396
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
[TBL] [Abstract][Full Text] [Related]
11. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
F1000Res; 2022; 11():30. PubMed ID: 35811795
[No Abstract] [Full Text] [Related]
12. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Empiric Antibacterial Therapy, Community-Acquired Bacterial Superinfection, and Antibiotic-Associated Adverse Reactions among Patients with COVID-19 Pneumonia Admitted in Makati Medical Center from March 2020 to March 2021.
Galang-De Leon WAM; Buensalido JAL
Infect Chemother; 2022 Jun; 54(2):266-274. PubMed ID: 35706084
[TBL] [Abstract][Full Text] [Related]
14. Bacterial infection, antibiotic use and COVID-19: Lessons from the intensive care unit.
Moolla MS; Reddy K; Fwemba I; Nyasulu PS; Taljaard JJ; Parker A; Louw EH; Nortje A; Parker MA; Lalla U; Koegelenberg CFN; Allwood BW
S Afr Med J; 2021 Apr; 111(6):575-581. PubMed ID: 34382570
[TBL] [Abstract][Full Text] [Related]
15. Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections.
Duan Y; Wang J; Wang S; Zhang R; Hu J; Li W; Chen B
Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):577-586. PubMed ID: 38246947
[TBL] [Abstract][Full Text] [Related]
16. Bacterial Coinfections in Coronavirus Disease 2019.
Westblade LF; Simon MS; Satlin MJ
Trends Microbiol; 2021 Oct; 29(10):930-941. PubMed ID: 33934980
[TBL] [Abstract][Full Text] [Related]
17. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
18. Observational Study on Secondary Bacterial Infection and the Use of Antibiotics in COVID-19 Patients Treated in a Tertiary Referral Hospital.
Lie KC; Shakinah S; Pasaribu A; Sinto R; Nainggolan L
Acta Med Indones; 2022 Apr; 54(2):161-169. PubMed ID: 35818653
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study.
Jorda A; Gabler C; Blaschke A; Wölfl-Duchek M; Gelbenegger G; Nussbaumer-Pröll A; Radtke C; Zeitlinger M; Bergmann F
Infection; 2024 Feb; 52(1):105-115. PubMed ID: 37326938
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
